Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis
- PMID: 29113028
- DOI: 10.1002/hep.29646
Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis
Abstract
Portal hypertension (PH) drives most of the clinical complications in chronic liver diseases. However, its progression in nonalcoholic steatohepatitis (NASH) and its association with the intestinal microbiota (IM) have been scarcely studied. Our aim was to investigate the role of the IM in the mechanisms leading to PH in early NASH. The experimental design was divided in two stages. In stage 1, Sprague-Dawley rats were fed for 8 weeks a high-fat, high-glucose/fructose diet (HFGFD) or a control diet/water (CD). Representative rats were selected as IM donors for stage 2. In stage 2, additional HFGFD and CD rats underwent intestinal decontamination, followed by IM transplantation with feces from opposite-diet donors (heterologous transplant) or autologous fecal transplant (as controls), generating four groups: CD-autotransplanted, CD-transplanted, HFGFD-autotransplanted, HFGFD-transplanted. After IM transplantation, the original diet was maintained for 12-14 days until death. HFGFD rats developed obesity, insulin resistance, NASH without fibrosis but with PH, intrahepatic endothelial dysfunction, and IM dysbiosis. In HFGFD rats, transplantation with feces from CD donors caused a significant reduction of PH to levels comparable to CD without significant changes in NASH histology. The reduction in PH was due to a 31% decrease of intrahepatic vascular resistance compared to the HFGFD-autotransplanted group (P < 0.05). This effect occurs through restoration of the sensitivity to insulin of the hepatic protein kinase B-dependent endothelial nitric oxide synthase signaling pathway.
Conclusion: The IM exerts a direct influence in the development of PH in rats with diet-induced NASH and dysbiosis; PH, insulin resistance, and endothelial dysfunction revert when a healthy IM is restored. (Hepatology 2018;67:1485-1498).
© 2017 by the American Association for the Study of Liver Diseases.
Similar articles
-
Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH.Sci Rep. 2019 Dec 27;9(1):20183. doi: 10.1038/s41598-019-56366-2. Sci Rep. 2019. PMID: 31882668 Free PMC article.
-
Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance.Sci Rep. 2018 Jan 23;8(1):1466. doi: 10.1038/s41598-018-19753-9. Sci Rep. 2018. PMID: 29362454 Free PMC article.
-
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.J Hepatol. 2017 Apr;66(4):806-815. doi: 10.1016/j.jhep.2016.11.008. Epub 2016 Nov 25. J Hepatol. 2017. PMID: 27890791
-
Potential mechanisms linking gut microbiota and portal hypertension.Liver Int. 2019 Apr;39(4):598-609. doi: 10.1111/liv.13986. Epub 2018 Nov 9. Liver Int. 2019. PMID: 30312513 Review.
-
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.Eur J Nutr. 2018 Apr;57(3):861-876. doi: 10.1007/s00394-017-1524-x. Epub 2017 Sep 5. Eur J Nutr. 2018. PMID: 28875318 Review.
Cited by
-
A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo.Biomedicines. 2022 May 20;10(5):1191. doi: 10.3390/biomedicines10051191. Biomedicines. 2022. PMID: 35625927 Free PMC article.
-
Intestinal Barrier and Permeability in Health, Obesity and NAFLD.Biomedicines. 2021 Dec 31;10(1):83. doi: 10.3390/biomedicines10010083. Biomedicines. 2021. PMID: 35052763 Free PMC article. Review.
-
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms.J Clin Transl Hepatol. 2023 Oct 28;11(5):1201-1211. doi: 10.14218/JCTH.2023.00029. Epub 2023 May 31. J Clin Transl Hepatol. 2023. PMID: 37577237 Free PMC article. Review.
-
Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective.Metabolites. 2024 Jun 7;14(6):324. doi: 10.3390/metabo14060324. Metabolites. 2024. PMID: 38921459 Free PMC article. Review.
-
Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice.J Clin Transl Hepatol. 2022 Oct 28;10(5):979-985. doi: 10.14218/JCTH.2021.00593. Epub 2022 Jul 19. J Clin Transl Hepatol. 2022. PMID: 36304507 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical